RT Conference Proceedings
T1 RESUNET (GETNE-2016-01): A phase II study to evaluate the efficacy and safety of the rechallenge with sunitinib in G1/G2 pancreatic neuroendocrine tumours (pNET). A Spanish Task Force Group in neuroendocrine and endocrine tumours (GETNE) study
A1 Grande, E.
A1 Espinosa-Olarte, P.
A1 Serrano, R.
A1 Jimenez, P.
A1 Alonso, T.
A1 Benavent, M.
A1 Capdevila Castillon, J.
A1 Lacasta, A.
A1 Yaya Tur, R.
A1 Carmona, A.
A1 Gallegos, I.
A1 Rodriguez, R. M.
A1 Castillo Trujillo, A. O.
A1 Molina Cerrillo, J.
A1 Hernando, J.
A1 Bujedo Martinez, A.
A1 Garcia-Carbonero, R.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/25711
UL https://hdl.handle.net/10668/25711
LA en
DS RISalud
RD Apr 4, 2025